We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$80B
AUM Growth
+$5.37B
Cap. Flow
-$213M
Cap. Flow %
-0.27%
Top 10 Hldgs %
23.95%
Holding
3,773
New
259
Increased
1,520
Reduced
1,671
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 14.42%
2 Healthcare 8.98%
3 Financials 7.75%
4 Consumer Discretionary 6.92%
5 Industrials 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZYXI
2176
DELISTED
Zynex
ZYXI
$972K ﹤0.01%
+61,246
New +$1.03M
TPTX
2177
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$967K ﹤0.01%
11,066
-266
-2% -$18.5K
CGC
2178
Canopy Growth
CGC
$422M
$965K ﹤0.01%
6,733
+917
+16% +$154K
PNTG icon
2179
Pennant Group
PNTG
$1.36B
$964K ﹤0.01%
24,992
-24,688
-50% -$757K
CADE
2180
DELISTED
Cadence Bank
CADE
$963K ﹤0.01%
49,672
+1,237
+3% +$26.4K
SHOP icon
2181
CALL
Shopify
SHOP
$199B
$961K ﹤0.01%
22,000
NVAX icon
2182
Novavax
NVAX
$1.31B
$960K ﹤0.01%
8,859
-3,203
-27% -$390K
INMD icon
2183
InMode
INMD
$873M
$956K ﹤0.01%
52,866
+5,780
+12% +$94.8K
XSMO icon
2184
Invesco S&P SmallCap Momentum ETF
XSMO
$3.12B
$956K ﹤0.01%
23,897
+3,922
+20% +$154K
WKHS icon
2185
Workhorse Group
WKHS
$33.8M
$952K ﹤0.01%
13
+6
+86% +$343K
ASB icon
2186
Associated Banc-Corp
ASB
$6.1B
$946K ﹤0.01%
+74,926
New +$992K
ZION icon
2187
Zions Bancorporation
ZION
$10.5B
$943K ﹤0.01%
32,289
-62,871
-66% -$2.03M
CDLX icon
2188
Cardlytics
CDLX
$24.6M
$940K ﹤0.01%
1,332
+790
+146% +$574K
GFL icon
2189
GFL Environmental
GFL
$15.1B
$938K ﹤0.01%
+44,120
New +$888K
HYS icon
2190
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.78B
$936K ﹤0.01%
9,976
-282
-3% -$26.4K
BKR icon
2191
Baker Hughes
BKR
$64.4B
$935K ﹤0.01%
70,333
+3,833
+6% +$58.6K
ELS icon
2192
Equity Lifestyle Properties
ELS
$12.7B
$932K ﹤0.01%
15,208
+2,482
+20% +$161K
ITRN icon
2193
Ituran Location and Control
ITRN
$1.08B
$927K ﹤0.01%
66,577
-594
-0.9% -$8.59K
GAB icon
2194
Gabelli Equity Trust
GAB
$1.8B
$923K ﹤0.01%
185,421
-39,245
-17% -$201K
LTC
2195
LTC Properties
LTC
$2.18B
$920K ﹤0.01%
26,405
+4,706
+22% +$174K
HQL
2196
abrdn Life Sciences Investors
HQL
$639M
$919K ﹤0.01%
52,268
-1,554
-3% -$27.8K
RWL icon
2197
Invesco S&P 500 Revenue ETF
RWL
$10B
$919K ﹤0.01%
17,040
-2,672
-14% -$144K
FLQL icon
2198
Franklin US Large Cap Multifactor Index ETF
FLQL
$2.11B
$918K ﹤0.01%
26,399
-1,247
-5% -$42.7K
IBP icon
2199
Installed Building Products
IBP
$6.44B
$918K ﹤0.01%
9,025
+6,039
+202% +$518K
ZWS icon
2200
Zurn Elkay Water Solutions
ZWS
$8.38B
$914K ﹤0.01%
+63,613
New +$908K

Similar funds

Raymond James & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Raymond James & Associates held 3,773 positions worth $80B, up 7.2% from $74.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2020 filing shows 259 new, 1,520 increased, 1,671 reduced and 192 closed positions. Its largest new stake was Rocket Companies: 405,835 shares worth $8.09M. The largest sale was Apple, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2020 buy was Rocket Companies: 405,835 shares worth $8.09M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2020, an estimated $140M increase.
  • Raymond James & Associates's biggest Q3 2020 reduction was Apple, cutting an estimated $134M.
  • Raymond James & Associates fully exited Invesco Russell 1000 Dynamic Multifactor ETF in Q3 2020, selling an estimated $15.9M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $80B portfolio in Q3 2020.
  • Raymond James & Associates opened 259 new positions and closed 192 in Q3 2020.
  • Raymond James & Associates's portfolio value rose 7.2% quarter-over-quarter to $80B.

Based on Raymond James & Associates's 13F filing for Q3 2020, filed 4 Nov 2020.